Prostate Cancer and You

In this episode of  Prostate Cancer and You , host Jordan Rich speaks with Dr. Todd Cohen of Blue Earth Diagnostics about the growing role of radioligand therapy in prostate cancer treatment. Dr. Cohen explains how PSMA-targeted imaging and radioligand therapy work together to identify and treat prostate cancer with greater precision. The discussion covers which patients may be candidates for thes...

Today’s “Prostate Cancer and You” podcast features Joshua Kraft, head of Kraft Family Philanthropies and former CEO of Boys & Girls Clubs of Boston. In this conversation with host Jordan Rich, Kraft discusses his experience with prostate cancer, sharing his journey from a PSA test to a Gleason score of 7. Kraft emphasizes the importance of early detection and treatment, as well as the signific...

Today’s “Prostate Cancer and You” podcast features Dr. Adam Kibel is chair of the department of urology at Mass General Brigham. In this conversation with host Jordan Rich, Dr. Kibel discusses a clinical trial focused on using genetic data and MRI to improve early detection of prostate cancer. The trial, involving men aged 40-69, aims to identify high-risk individuals through genetic testing and t...

In this second of a two-part podcast episode, Dr. Todd Cohen discusses the role of PSMA PET imaging in prostate cancer active surveillance, highlighting its potential to replace invasive biopsies. Cohen emphasizes the importance of communication and family involvement in active surveillance protocols. Advanced imaging technologies are evolving, offering hope for less invasive and more effective ca...

In this first of a two-part podcast episode of “Prostate Cancer and You,” brought to you in part by Blue Earth Diagnostics, Dr. Todd Cohen, Blue Earth Diagnostics vice-president of medical affairs, discusses the practice of active surveillance in prostate cancer screening. Cohen explains the advancements in imaging, particularly PSMA PET scans, which have revolutionized prostate cancer detection....

Today’s “Prostate Cancer and You” podcast features Dr. Jean Joseph, chairman of the department of urology at the University of Rochester Medical Center and keynote at the May 2025 MPCC Symposium. In this conversation with host Jordan Rich, Dr. Joseph furthers his keynote topics, discussing the history, benefits, and future development of robotic surgery for prostate cancer. The technology, initial...

In this second of a two-part podcast episode detailing new treatments for prostate cancer, Dr. Phillip Davis and Dr. Dan Stevens highlight the increasing accessibility of molecular imaging and radioligy and therapy across the US and the potential for earlier use of these technologies. They also discuss the promise of future advancements including personalized cancer treatments, the use of new radi...

In this first of a two-part podcast episode, Dr. Phillip Davis and Dr. Dan Stevens follow up on the symposium topic of “New Treatments for Prostate Cancer.” In Part I, Dr. Philip Davis explains molecular imaging, which uses a low dose of radioactive medicine to detect cancer and other diseases early, as well as providing doctors with both anatomic and functional information on the cancer cells. Dr...

Today’s podcast in the “Prostate Cancer and You” series features Dr. Preston Sprenkle, Associate Professor of Urology at Yale University, and Robert Palmer, a marketing executive and prostate cancer survivor. In this conversation with host Jordan Rich, Bob Palmer discusses his experience of incision-free ablation intervention as a cancer treatment. Here is a link to more details about Bob’s choice...

Today’s podcast in the “Prostate Cancer and You” series features Dr. Fay Shtern, the president of AdMeTech Foundation. In this conversation, Dr. Shtern and host Jordan Rich discuss the AdMeTech Foundation’s Prostate Cancer Equity Program and how men in and out of Massachusetts can participate. For more information on AdMeTech Foundation and its Prostate Cancer Equity program, visit www.admetech.or...

Join us for a special edition of “Prostate Cancer and You,” a podcast in honor of Prostate Cancer Awareness Month 2024. In this episode, we dive into one man’s personal journey, from active surveillance to cutting-edge PSMA PET technology, to shape his treatment plan. Since its establishment in 1999 and official recognition as National Prostate Cancer Awareness Month in 2003, this annual obs...

Today’s podcast in the “Prostate Cancer and You” series, brought to you in part by Blue Earth Diagnostics, features Dr. David Yang, attending physician in the Department of Radiation Oncology at Brigham and Women’s Hospital/Dana-Farber Cancer Institute, and Dr. Todd Cohen, Blue Earth Diagnostics vice-president of medical affairs. This conversation further explores the topics presented in the MPCC...

Today’s podcast in the “Prostate Cancer and You” series, brought to you in part by Blue Earth Diagnostics, features filmmaker Landi Maduro, the producer of The Silent Killer: Prostate Cancer in the African American Community . Continuing the conversation from her podcast appearance last year, Landi and interviewer Jordan Rich discuss the story behind making the documentary, its continued relevance...

The latest MPCC podcast features John Colbert, Creative Director of Colbert Studios and son of MPCC founder Jack Colbert. John joined the MPCC board in November, and he is bringing his expertise to the organization as plans are underway for a new look, rebranding, and refined mission for the new year. In this conversation, he discusses the goals of the rebranding, including presenting MPCC as a “p...

Listen to the latest MPCC podcast, brought to you in part by Blue Earth Diagnostics, as Mark Franklin, prostate cancer survivor, Alain Chaglassian, MD, MPH, Blue Earth Diagnostics, and Adam Kibel, MD, Brigham and Women’s Hospital, and MPCC Medical Advisory Committee,  discuss the history of imaging and provide more information on PMSA imaging for prostate cancer.

The third podcast in this series features Londi Maduro, a film maker in California. Her film The Silent Killer: Prostate Cancer in the African American Community explores the myths, fears, and concerns about the disease. It follows several men who are all battling prostate cancer, focusing on how they’re dealing with their diagnoses, what treatment they decided to pursue, and how the disease has a...

The second podcast in “Disparities, Awareness, and Access to Health Care in the African America community“ features Mark Kennedy from the Boston Public Health Commission and Dr. Jacques Carter from Beth Israel Lahey and a member of the MPCC Medical Advisory Committee as they discuss how government institutions and health care organizations can work together with patients, families and organization...

The first in a three-part series on “Disparities, Awareness, and Access to Health Care in the African American Community” features Archie Emmanuel Jr, Lamont Scott, and Brother Al from MOCHA (Men of Color Health Awareness) located in Springfield, Massachusetts. Listen to their own personal stories on the importance of prostate cancer awareness as well as the learning more about the services that M...

Thanks to Dr. Karen E. Knudsen, CEO of the American Cancer Society, for joining the MPCC podcast series, Prostate Cancer & You. In this interview. She provides an outstanding overview of ACS and the latest thinking and activities that she and her colleagues are undertaking with regard to prostate cancer.

In this sixth episode, Michael A. DiSpezio discusses Kegels (aka pelvic floor exercises) and their role in regaining urinary continence. Then, he takes a deeper dive into shared decision making, and why it is essential for all patients to be an active part of this critical process. Michael discusses the advantages of focal therapy (not appropriate for all) as he describes several ablation treatmen...

In this fifth episode, Michael A. DiSpezio discusses the quality of life and how it changed following radical prostatectomy. Michael explains the basic difference between external beam radiation and the implantation of radioactive seeds, what radiation does, and addresses the side effects associated with this type of treatment. He introduces hormone therapy and how it is sometimes used alongside o...

In this fourth episode, Michael A. DiSpezio addresses the first PSA test following surgery and what that means as far as the tumor’s spread. He then presents the basics of cancer in terms of cells and DNA. Then, Michael discusses the likelihood of a man getting prostate cancer and how this disease disproportionately impacts African American men. In addition, he explains why prostate illnesses are...

In this third episode, Michael addresses the concept of quality of life and how one’s choice of treatment impacts the future. He profiles his own challenges with post-operative side effects including urinary incontinence, bowel issues, erectile dysfunction and the emotional turmoil associated with treatments. He addresses the surgical pathology report and how the results are interpreted in terms o...

In this second episode, Michael presents the basics of decision making as it pertains to critical choices he faced, including selecting the type of prostate biopsy. He explains what is communicated in a biopsy pathology report. In addition, Michael introduces us to a radical prostatectomy using a robotic-assisted procedure, along with the reported advantages of high-volume surgeons. He concludes t...

In this first episode, Michael introduces us to his personal journey with prostate cancer. It begins with addressing PSA and the role of this tumor marker in risk assessment for prostate cancer. He discusses active surveillance as a treatment option, family history, symptoms (and in his case, a lack of symptoms), and the need to expand one’s health care team to include a urologist. He concludes th...